BMW’s CEO expects chip shortage to last into 2023
BERLIN (Reuters) – A shortage of semiconductors is likely to remain a problem for the auto industry into 2023, German carmaker BMW’s Chief Executive Oliver Zipse said in an interview.
BERLIN (Reuters) – A shortage of semiconductors is likely to remain a problem for the auto industry into 2023, German carmaker BMW’s Chief Executive Oliver Zipse said in an interview.
By Wayne Cole SYDNEY (Reuters) – Shares slid and bond yields climbed on Monday as caution gripped markets ahead of central bank meetings and U.S. inflation data, while the euro.
By Katie Paul and Munsif Vengattil (Reuters) – Days after the March 9 bombing of a maternity and children’s hospital in the Ukrainian city of Mariupol, comments claiming the attack.
By Scott Murdoch HONG KONG (Reuters) – Chinese question-and-answer website Zhihu Inc opened its bookbuilding process on Monday to raise $133 million in a dual primary listing in Hong Kong,.
(Reuters) -The chairman of Vietnam’s Vingroup conglomerate said on Saturday that the company’s auto unit, VinFast, would seek financing from the U.S. government to support its expansion with a planned.
BERLIN (Reuters) – Volkswagen (DE:VOWG_p) has rejected a shareholder proposal for it to explain how its lobbying activities align with its climate goals – something two of the carmaker’s leading.
(Reuters) -YouTube has blocked Duma TV which broadcasts from Russia’s lower house of parliament, drawing an angry response from officials who said the world’s most popular streaming service could face.
LONDON (Reuters) – Russia faces its first sovereign external default in over a century after it made arrangements to make an international bond repayment in roubles earlier this week, even.
(Reuters) – Elon Musk, Twitter Inc (NYSE:TWTR)’s biggest shareholder, on Saturday suggested a raft of changes to the social media giant’s Twitter Blue premium subscription service, including slashing its price, banning advertising.
By Deena Beasley (Reuters) – Eisai Co (OTC:ESALY) Ltd and Eli Lilly (NYSE:LLY) and Co on Friday said they still plan to seek accelerated U.S. approval for experimental Alzheimer’s drugs.